NASDAQ:CARA
Cara Therapeutics Stock News
$0.684
-0.0157 (-2.24%)
At Close: Apr 26, 2024
Cara Therapeutics, Inc. (CARA) to Present at the 23rd Annual Needham Virtual Healthcare Conference
09:02am, Tuesday, 02'nd Apr 2024
Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Ch
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
07:00am, Tuesday, 02'nd Apr 2024
STAMFORD, Conn., April 02, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of pati
Cara Therapeutics, Inc. (CARA) Q4 2023 Earnings Call Transcript
07:07pm, Monday, 04'th Mar 2024
Cara Therapeutics, Inc. (NASDAQ:CARA ) Q4 2023 Earnings Call Transcript March 4, 2024 4:30 PM ET Company Participants Matt Murphy - Manager, IR Chris Posner - CEO Ryan Maynard - CFO Joana Goncalves -
Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
06:11pm, Monday, 04'th Mar 2024
Cara Therapeutics (CARA) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.57. This compares to loss of $0.56 per share a year ago.
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
01:37pm, Sunday, 25'th Feb 2024
While targeting the therapeutic side of the healthcare sector can be quite lucrative, nothing matches the excitement of biotech penny stocks. Of course, the excitement goes toward both extremes of the
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
04:01pm, Monday, 12'th Feb 2024
STAMFORD, Conn., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) today announced the Company will host a conference call and live audio webcast on Monday, March 4, 2024, at 4
CARA's Late-Stage Skin Disease Study Fails, Stock Plummets 49%
01:32pm, Tuesday, 19'th Dec 2023
CARA discontinues the clinical program of oral difelikefalin for pruritus associated with atopic dermatitis following the failure of dose-finding Part A of the late-stage study. Stock plunges 49%.
Cara (CARA) Reports Q3 Earnings: What Key Metrics Have to Say
07:32pm, Monday, 13'th Nov 2023
The headline numbers for Cara (CARA) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023
07:00am, Monday, 23'rd Oct 2023
STAMFORD, Conn., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patien
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
06:54pm, Monday, 07'th Aug 2023
Cara Therapeutics (CARA) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.08 per share a year ago.
Cara Therapeutics, Inc. (CARA) Q2 2023 Earnings Call Transcript
06:13pm, Monday, 07'th Aug 2023
Cara Therapeutics, Inc. (NASDAQ:CARA ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Matthew Murphy - Manager, IR Christopher Posner - President, CEO & Director Ryan
Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023
07:00am, Monday, 24'th Jul 2023
STAMFORD, Conn., July 24, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patien
Cara Therapeutics Faces Uncertainty Despite Potential Reimbursement Extension For Korsuva
05:11pm, Friday, 14'th Jul 2023
Cara Therapeutics' Korsuva injection, approved for treating pruritus in adults with chronic kidney disease, may have its reimbursement period extended to 2027 by the US Medicare and Medicaid Services,
3 Small-Cap Stocks to Sell in June Before They Crash and Burn
06:30am, Tuesday, 13'th Jun 2023
Small-cap stocks, defined by a market capitalization between $300 million and $2 billion, can tempt investors looking for quick returns. However, these small-cap stocks to avoid can be incredibly vola
Cara Therapeutics to Present at the Jefferies Healthcare Conference
07:00am, Thursday, 01'st Jun 2023
STAMFORD, Conn., June 01, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patien